Race against time: testing babies for HIV at birth to start Life-Saving drugs immediately
NCT ID NCT05393193
Summary
This study aims to quickly identify HIV in newborns at high risk by testing them right after birth at the hospital. If a baby tests positive, they are immediately offered a modern HIV medication called dolutegravir and followed for two years to see how well they do. The goal is to prevent the virus from causing serious illness by starting treatment as early as possible.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Botswana Harvard Health Partnership
Gaborone, Botswana
Conditions
Explore the condition pages connected to this study.